<DOC>
	<DOCNO>NCT01907113</DOCNO>
	<brief_summary>Assessment effect normal impaired kidney function pharmacokinetics , pharmacodynamics safety BI 10773</brief_summary>
	<brief_title>Pharmacokinetics , Pharmacodynamics , Safety Tolerability BI 10773 Type II Diabetes Patients With Different Degrees Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female subject type 2 diabetes 2 . Renally impaired male female subject 3 . Age 18 75 year 4 . BMI 18 34 kg/m2 , least 45 kg female ( Body Mass Index ) 5 . Signed date write informed consent Exclusion criterion : 1 . Significant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder judge investigator . 2 . Relevant gastrointestinal tract surgery 3 . Diseases central nervous system ( epilepsy , seizure ) psychiatric disorder relevant neurological disorder 4 . History relevant orthostatic hypotension , faint spell blackout ; systolic blood pressure &lt; 100 &gt; 160 mm Hg , diastolic blood pressure &lt; 60 &gt; 100 mm Hg , pulse rate &lt; 50 &gt; 100 1/min 5 . Chronic relevant acute infection 6 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 7 . Use within 10 day prior administration trial drug might reasonably influence result trial base knowledge time protocol preparation . Co medication know inhibit induce Pglycoprotein CYP3A allow . Inhibitors Pglycoprotein CYP3A ( cytochrom P3A ) e.g . protease inhibitor , ( e.g . ritonavir , lopinavir nelfinavir ) azole antimycotic , ( itraconazole , ketoconazole , miconazole ) macrolid antibiotic , ( clarithromycin , erythromycin ) amiodarone , cimetidine , diltiazem , fluvoxamine , mibefradil , nefazodone , verapamil , tacrolimus , quinidine , reserpine , cyclosporine A Inducers Pgp CYP3A e.g . carbamazepine , phenobarbital , phenytoin , rifabutin , rifampin , St. John 's wort , troglitazone . In dubious case , case case decision make consultation sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>